ATE533489T1 - Behandlung von multiplem myelom - Google Patents
Behandlung von multiplem myelomInfo
- Publication number
- ATE533489T1 ATE533489T1 AT07846860T AT07846860T ATE533489T1 AT E533489 T1 ATE533489 T1 AT E533489T1 AT 07846860 T AT07846860 T AT 07846860T AT 07846860 T AT07846860 T AT 07846860T AT E533489 T1 ATE533489 T1 AT E533489T1
- Authority
- AT
- Austria
- Prior art keywords
- multiple myeloma
- treatment
- subject
- administering
- treating
- Prior art date
Links
- 208000034578 Multiple myelomas Diseases 0.000 title abstract 2
- 206010035226 Plasma cell myeloma Diseases 0.000 title abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US86112006P | 2006-11-27 | 2006-11-27 | |
| US90413807P | 2007-02-28 | 2007-02-28 | |
| PCT/EP2007/010299 WO2008064866A1 (en) | 2006-11-27 | 2007-11-27 | Treatment for multiple myeloma |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE533489T1 true ATE533489T1 (de) | 2011-12-15 |
Family
ID=39157918
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT07846860T ATE533489T1 (de) | 2006-11-27 | 2007-11-27 | Behandlung von multiplem myelom |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20100069316A1 (de) |
| EP (1) | EP2139482B1 (de) |
| JP (1) | JP2010510971A (de) |
| KR (1) | KR20090093965A (de) |
| AT (1) | ATE533489T1 (de) |
| AU (1) | AU2007324850A1 (de) |
| CA (1) | CA2669128C (de) |
| EA (1) | EA200970512A1 (de) |
| ES (1) | ES2377717T3 (de) |
| IL (1) | IL198901A0 (de) |
| MX (1) | MX2009005649A (de) |
| WO (1) | WO2008064866A1 (de) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HUE029196T2 (en) | 2010-06-04 | 2017-02-28 | Hoffmann La Roche | Aminoprimidine derivatives as LRRK2 modulators |
| SG189043A1 (en) | 2010-11-10 | 2013-05-31 | Hoffmann La Roche | Pyrazole aminopyrimidine derivatives as lrrk2 modulators |
| AP2013007281A0 (en) * | 2011-05-02 | 2013-11-30 | Ym Biosciences Australia Pty | Multiple myeloma treatment |
| JP6340361B2 (ja) * | 2012-04-13 | 2018-06-06 | エピザイム，インコーポレイティド | がんを処置するための組合せ治療 |
| KR101471273B1 (ko) * | 2013-01-29 | 2014-12-11 | 인제대학교 산학협력단 | Ｓｏｄ２를 포함하는 보르테조밉 내성 진단용 바이오 마커 조성물 및 이를 이용한 진단 키트 |
| US11066404B2 (en) | 2018-10-11 | 2021-07-20 | Incyte Corporation | Dihydropyrido[2,3-d]pyrimidinone compounds as CDK2 inhibitors |
| US11384083B2 (en) | 2019-02-15 | 2022-07-12 | Incyte Corporation | Substituted spiro[cyclopropane-1,5′-pyrrolo[2,3-d]pyrimidin]-6′(7′h)-ones as CDK2 inhibitors |
| US11472791B2 (en) | 2019-03-05 | 2022-10-18 | Incyte Corporation | Pyrazolyl pyrimidinylamine compounds as CDK2 inhibitors |
| WO2020205560A1 (en) | 2019-03-29 | 2020-10-08 | Incyte Corporation | Sulfonylamide compounds as cdk2 inhibitors |
| US11440914B2 (en) | 2019-05-01 | 2022-09-13 | Incyte Corporation | Tricyclic amine compounds as CDK2 inhibitors |
| US11447494B2 (en) | 2019-05-01 | 2022-09-20 | Incyte Corporation | Tricyclic amine compounds as CDK2 inhibitors |
| MX2022001940A (es) | 2019-08-14 | 2022-05-10 | Incyte Corp | Compuestos de imidazolil pirimidinilamina como inhibidores de cdk2. |
| CN119930610A (zh) | 2019-10-11 | 2025-05-06 | 因赛特公司 | 作为cdk2抑制剂的双环胺 |
| US11981671B2 (en) | 2021-06-21 | 2024-05-14 | Incyte Corporation | Bicyclic pyrazolyl amines as CDK2 inhibitors |
| US11976073B2 (en) | 2021-12-10 | 2024-05-07 | Incyte Corporation | Bicyclic amines as CDK2 inhibitors |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7618630B2 (en) * | 1998-09-14 | 2009-11-17 | Board Of Regents, The University Of Texas System | Methods of treating multiple myeloma and myeloma-induced bone resorption using integrin antagonists |
| US7129242B2 (en) * | 2000-12-06 | 2006-10-31 | Signal Pharmaceuticals, Llc | Anilinopyrimidine derivatives as JNK pathway inhibitors and compositions and methods related thereto |
| WO2002062792A1 (en) * | 2001-02-02 | 2002-08-15 | Takeda Chemical Industries, Ltd. | Jnk inhibitor |
| US6864047B2 (en) * | 2001-03-29 | 2005-03-08 | Mayo Foundation For Medical Education And Research | IL1-β: a new target for myeloma therapy |
| JP4316893B2 (ja) * | 2001-05-16 | 2009-08-19 | バーテックス ファーマシューティカルズ インコーポレイテッド | Ｓｒｃおよび他のプロテインキナーゼのインヒビター |
-
2007
- 2007-11-27 ES ES07846860T patent/ES2377717T3/es active Active
- 2007-11-27 AU AU2007324850A patent/AU2007324850A1/en not_active Abandoned
- 2007-11-27 CA CA2669128A patent/CA2669128C/en not_active Expired - Fee Related
- 2007-11-27 KR KR1020097010875A patent/KR20090093965A/ko not_active Withdrawn
- 2007-11-27 MX MX2009005649A patent/MX2009005649A/es unknown
- 2007-11-27 AT AT07846860T patent/ATE533489T1/de active
- 2007-11-27 EA EA200970512A patent/EA200970512A1/ru unknown
- 2007-11-27 EP EP07846860A patent/EP2139482B1/de active Active
- 2007-11-27 WO PCT/EP2007/010299 patent/WO2008064866A1/en not_active Ceased
- 2007-11-27 US US12/312,763 patent/US20100069316A1/en not_active Abandoned
- 2007-11-27 JP JP2009537563A patent/JP2010510971A/ja not_active Withdrawn
-
2009
- 2009-05-21 IL IL198901A patent/IL198901A0/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| ES2377717T3 (es) | 2012-03-30 |
| WO2008064866A8 (en) | 2008-10-02 |
| EP2139482B1 (de) | 2011-11-16 |
| MX2009005649A (es) | 2009-06-08 |
| WO2008064866A1 (en) | 2008-06-05 |
| US20100069316A1 (en) | 2010-03-18 |
| CA2669128C (en) | 2011-07-12 |
| JP2010510971A (ja) | 2010-04-08 |
| AU2007324850A1 (en) | 2008-06-05 |
| KR20090093965A (ko) | 2009-09-02 |
| IL198901A0 (en) | 2010-02-17 |
| EP2139482A1 (de) | 2010-01-06 |
| EA200970512A1 (ru) | 2009-12-30 |
| AU2007324850A2 (en) | 2009-07-02 |
| CA2669128A1 (en) | 2008-06-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE533489T1 (de) | Behandlung von multiplem myelom | |
| EA201290677A1 (ru) | Соединения обратного амида в качестве ингибиторов протеиндеацетилазы и способы их применения | |
| EA201070328A1 (ru) | Соединения триазолопиридина и их применение в качестве ингибиторов ask | |
| EA201000895A1 (ru) | Композиции и способы для лечения лизосомных болезней | |
| UA110338C2 (xx) | Хімічні сполуки | |
| EA200700851A1 (ru) | Получение и применение бифенил-4-илкарбониламинокислотных производных для лечения ожирения | |
| EA201290919A1 (ru) | Индазольные соединения и их применение | |
| EA201100750A1 (ru) | Замещенные диоксопиперидинилфталимидные производные | |
| EA201300860A1 (ru) | Кристаллические трипептидные ингибиторы эпоксикетон-протеазы | |
| EA201200917A1 (ru) | Пролекарства ингибиторов плазменного калликреина | |
| EA201200373A1 (ru) | Соединения и композиции в качестве ингибиторов протеинкиназ | |
| EA201100447A1 (ru) | Органические соединения | |
| EA201170344A1 (ru) | Азаиндольные ингибиторы iap | |
| CY1115262T1 (el) | Ανταγωνιστες trpv1 και χρησεις αυτων | |
| EA201890768A2 (ru) | Лечение злокачественной опухоли ингибиторами tor-киназы | |
| EA201391591A1 (ru) | Лечение множественной миеломы | |
| EA201291099A1 (ru) | Новые иммуномодуляторные и противовоспалительные соединения | |
| GEP20146131B (en) | Carbazole compounds and therapeutic uses thereof | |
| EA201170832A1 (ru) | Пуриновые соединения | |
| EA200971141A1 (ru) | Соединения, активирующие теломеразу, и способы их применения | |
| EA201070442A1 (ru) | НОВЫЕ ИНГИБИТОРЫ sEH И ИХ ПРИМЕНЕНИЕ | |
| UA107562C2 (uk) | Спосіб лікування псоріазу | |
| ATE517873T1 (de) | 6-oxo-1,6-dihydropyrimidin-2-yle bei der behandlung proliferativer krankheiten | |
| EA201100874A1 (ru) | Соединения для лечения рака | |
| EA201170425A1 (ru) | Тетрациклиновые соединения для лечения ревматоидного артрита и связанные с ними способы лечения |